Caris Life Sciences to Present Eight Studies Highlighting the Power of AI, Multi-Omics and Precision Medicine at ESMO 2026
PR Newswire•14/10/2026•08:30 ET
0
Key Highlights
- ➤Caris (CAI) will present eight ESMO 2026 posters spanning five cancer research areas.
- ➤Two Caris-led studies use AI for breast-cancer treatment prediction and risk-benefit stratification.
- ➤Six Caris POA collaborations examine biomarkers, immunotherapy, metastasis and survival outcomes.
- ➤ESMO Congress 2026 runs October 23-27 in Madrid, Spain.
Expert Statements
James Hamrick, Chairman of the Caris Precision Oncology Alliance
“Artificial intelligence is transforming our ability to understand cancer biology and predict therapeutic response on an unprecedented scale”
James Hamrick, Chairman of the Caris Precision Oncology Alliance
“The posters to be presented at ESMO 2026 highlight how the integration of AI, molecular profiling and real-world clinical data can uncover clinically meaningful insights that ultimately help guide more precise treatment decisions for patients.”
Caris Life Sciences to Present Eight Studies Highlighting the Power of AI, Multi-Omics and Precision Medicine at ESMO 2026 PR Newswire
Eight posters will feature AI-driven approaches to treatment prediction, risk stratification and biomarker discovery advancing precision medicine across multiple cancer types
Get started
Create a free account to read the full story.